(S)-1-(3-CHLOROPYRIDIN-2-YL)ETHANAMINE HCL, 95.0%, 250mg

1-Naphthoyl Cyanide>98.0%(GC)(N)5g

Benzofuran-5-ylboronic acid, 95.0%, 100mg

tert-Butyl N-(2-((4-(4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl)amino)ethyl)sulfamoylcarbamate, 97%, 250mg

4-Methyl-1,3-dioxane, 95.0%, 25g

4-Bromo-1H-indole-6-carboxylic acid, 95.0%, 1g

2,6-DPPEAQ>90.0%(T)5g

(2-Isopropyl-benzoimidazol-1-yl)-acetic acid, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-35 MS, L 30 m, Ø-Innen 0,32 mm, Filmd. 0,25 µm, 1 Stück

3-methyl-2,4-dihydro-1,2-benzoxazol-4-one, 96%, 100mg

2-Chloro-6-methoxypyridine-4-boronic acid, 98%, 1g

(2-chloro-3-quinolinyl)methanol, 95.0%, 5g

2-phenylazetidine, 95.0%, 10g